Retour
56
Fourchette du Jour
0,19 €
0,19 €
Fourchette 52 Semaines
0,05 €
0,21 €
Volume
300
Moyenne 50J / 200J
0,18 €
/
0,12 €
Clôture Précédente
0,19 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -7,9 | 0,3 |
| P/B | 0,4 | 2,9 |
| ROE % | -4,9 | 3,7 |
| Net Margin % | -11,4 | 3,8 |
| Rev Growth 5Y % | -6,3 | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,11 €
0,11 € – 0,11 €
|
4,4 B | 1 |
| FY2026 |
0,08 €
0,08 € – 0,08 €
|
3,4 B | 1 |
Points Clés
Revenue declined -6,28% annually over 5 years
Debt/Equity of 0,22 — conservative balance sheet
Generating 57,51M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8,46%
Capital efficient — spends only 9,80% of revenue on capex
Croissance
Revenue Growth (5Y)
-6,28%
Revenue (1Y)2,18%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-4,92%
ROIC-1,94%
Net Margin-11,40%
Op. Margin-7,27%
Sécurité
Debt / Equity
0,22
Current Ratio1,73
Interest Coverage-0,50
Valorisation
P/E Ratio
-7,87
P/B Ratio0,39
EV/EBITDAN/A
Dividend Yield0,05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,18% | Revenue Growth (3Y) | -6,64% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -6,28% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,90B | Net Income (TTM) | -216,66M |
| ROE | -4,92% | ROA | -2,06% |
| Gross Margin | 65,32% | Operating Margin | -7,27% |
| Net Margin | -11,40% | Free Cash Flow (TTM) | 57,51M |
| ROIC | -1,94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,22 | Current Ratio | 1,73 |
| Interest Coverage | -0,50 | Dividend Yield | 0,05% |
| Valuation | |||
| P/E Ratio | -7,87 | P/B Ratio | 0,39 |
| P/S Ratio | 0,90 | PEG Ratio | -0,05 |
| EV/EBITDA | N/A | Dividend Yield | 0,05% |
| Market Cap | 1,71B | Enterprise Value | -942,07M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1,90B | 1,86B | 2,18B | 3,04B | 2,46B |
| Net Income | -216,66M | -54,02M | -1,91B | 416,51M | 473,38M |
| EPS (Diluted) | -0,02 | -0,01 | -0,21 | 0,04 | 0,05 |
| Gross Profit | 1,24B | 1,30B | 1,49B | 2,43B | 1,91B |
| Operating Income | -138,13M | 161,70M | -1,83B | 771,95M | 787,13M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 10,53B | 11,54B | 12,14B | 14,50B | 13,04B |
| Total Liabilities | 5,58B | 6,40B | 6,50B | 5,35B | 3,10B |
| Shareholders' Equity | 4,37B | 4,43B | 4,74B | 8,28B | 9,19B |
| Total Debt | 974,01M | 1,26B | 1,29B | 1,08B | 755,05M |
| Cash & Equivalents | 3,62B | 3,89B | 3,83B | 5,68B | 4,60B |
| Current Assets | 5,72B | 6,20B | 6,55B | 7,74B | 6,40B |
| Current Liabilities | 3,31B | 4,11B | 2,53B | 2,50B | 2,44B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#205 of 827
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026